BioMedWire Stocks Archives - Page 8 of 77

TuesdaySep 30, 2025 10:00 am

Scorpion Venom Shows Promise in Brain Tumor Treatment

The sight of a scorpion moving towards you with its stinger raised can send a chill down the spine of the bravest among us. If you watched Fear Factor, you saw how terrified the contestants were to come face to face with these creatures. While scorpions have been portrayed as the stuff of nightmares, scientists have found that they can be useful in the fight against brain cancer. The study, which was conducted by City of Hope, a consortium of research centers in different cities around America focused on studying cancer, suggests that scorpion venom can help to guide our…

FridaySep 26, 2025 10:00 am

Landmark Study Shows How Menopause Influences the Symptoms of Multiple Sclerosis

Groundbreaking research presented at the ECTRIMS 2025 conference held in Barcelona, Spain provides new insights into the ways in which menopause impacts the health implications and clinical manifestations in women who have multiple sclerosis. This study shows that changes in hormones influence the initial symptoms experienced by women with MS and also play a role in the comorbidities suffered by the affected individuals. It has been known that MS disproportionately impacts women and the progression of the disease is influenced by the biological variables of the different sexes. However, the role that menopause plays in people with this disease hasn’t…

TuesdaySep 23, 2025 10:00 am

How Federal Policies are Making Health Care More Costly for Families

Most American families are very concerned about health care costs, and recent policy decisions at the federal level will increase the costs that families have to incur for health care. We discuss some of those policy decisions that are causing an uptick in the cost of health care. For starters, the tariffs announced by President Trump and those he is threatening to impose will make the cost of importing prescription drugs into the U.S. higher. As companies incur higher costs to bring in drugs, those additional costs will inevitably be passed on to patients and their caregivers. Given that many…

FridaySep 19, 2025 10:00 am

UCLA Researchers Receive $2M Grant to Study MRI-Guided Cancer Radiation Therapy

A grant of $2 million has been awarded to UCLA Health by a for-profit company, ViewRay Systems. The purpose of this grant is to enable the university to accelerate its research efforts in finding ways in which MRI-guided radiation therapy can be leveraged to provide targeted treatment to cancer patients. Cancer treatments, such as radiation and chemotherapy, are known to impact both diseased and healthy tissues. The impact on healthy tissue causes a variety of side effects, such as hair loss and weight loss, which can affect the health and quality of life of patients. Efforts have therefore been made…

ThursdaySep 18, 2025 10:00 am

New Research Suggests Dietary Change Could Improve Glioblastoma Treatment Outcomes

Researchers at the University of Michigan have published a study which suggests that implementing a dietary adjustment could make glioblastoma, a deadly type of brain cancer, more susceptible to chemotherapy and radiation treatments targeting the tumors in the brain. The study, whose findings appeared in the Nature journal on September 3, suggests that when scientists gain deep understanding of the different mechanisms through which tumor cells alter their metabolic systems inside a patient to boost the proliferation of the tumor, it could unlock novel ways to fight this cancer that has so far been very difficult to treat. Professor Costas…

TuesdaySep 16, 2025 10:00 am

New Smart Pen Shows 96% Efficacy in Detecting Parkinson’s Disease

UCLA researchers have developed a smart pen that can detect Parkinson’s during its early stages when the symptoms relied upon for the usual way to diagnose it haven’t shown up yet. Initial tests of this pen revealed an accuracy rate of 96.22%. Currently, Parkinson’s is usually detected when it has advanced so much that it is difficult for existing medications to have any impact in slowing down its progression. This smart pen developed by the UCLA researchers offers an affordable and accessible way to leverage simple acts like writing on a piece of paper to detect the disease long before…

FridaySep 12, 2025 10:00 am

Study Finds That Common Sweetener Could Compromise Cancer Treatment Effectiveness

Researchers at University of Pittsburg have found that patients who consume sucralose regularly have a lower likelihood of benefiting from immunotherapy and having longer survival times. Sucralose is an artificial sweetener that is commonly used in a variety of diet products, such as Splenda. This research is the first to connect the dietary choices that people make to groundbreaking cancer treatments. For their study, the team obtained the dietary data of 91 patients diagnosed with advanced melanoma. They also obtained similar data from 41 patients having lung cancer. The patients whose daily intake of sucralose exceeded 0.07mg for each pound…

ThursdaySep 11, 2025 10:00 am

Kennedy’s MAHA Plan to Make Kids Healthier Receives Mixed Reactions

On Tuesday, the U.S. federal administration published a report aimed at improving the health of children in the country. The report calls for wide-ranging policy changes and executive actions to tackle the chronic disease burden rising in the country. HHS Secretary Kennedy Jr. announced this report. However, reactions to the contents of the report have been mixed. Speaking during the release, Kennedy hailed the 128 recommendations contained in the report as “unprecedented and historic” in addressing the “existential threat” posed by chronic diseases in American kids. Many researchers and experts say the report is rich in rhetoric but thin on…

TuesdaySep 09, 2025 10:00 am

Senior NIH Officials Allege Retaliation as Motive for Their Ouster

Two former officials at the NIH have filed whistleblower complaints in which they allege that their removal from office was a result of their resistance to giving politics priority over science and their efforts to defend vaccines and research grants. They filed their complaints last week. Back in April, Kathleen Neuzil and Jeanne Marazzo were put on administrative leave from their NIH top positions. In their complaints filed last week at the United States Office of Special Counsel, they claim that the work environment at the NIH after Robert F. Kennedy Jr. took over as HHS Secretary became hostile to…

FridaySep 05, 2025 10:00 am

NCI Halts Funding for Consortium Conducting Trials on Childhood Brain Cancers

The NCI, or National Cancer Institute, a federal body, has revealed that it will no longer fund a program that has been running for 26 years focused on advancing clinical studies on children with brain cancers. The group, Pediatric Brain Tumor Consortium, was founded in 1999 to bring together 15 academic institutions and pediatric hospitals within the United States and Canada to conduct early-stage clinical trials (Phase 1 and Phase 2). This consortium has a record of conducting trials aimed at exploring new therapies, strategies for delivering radiation treatment, and finding new technologies to deliver treatments specifically focused on pediatric…